Cardiothoracic & vascular anesthesia
Remimazolam in Cardiac Anesthesia: Analysis of Recent Data
Authors' conclusion
The analysis shows that remimazolam offers anesthesia without significant hemodynamic instability and a reduced need for vasopressors, with an incidence of perioperative adverse events comparable to that of other agents.
Study context
- Population
- Cardiovascular anesthesia: catheterization laboratory procedures and elective cardiac surgery
- Comparison
- Remimazolam vs other anesthetic agents
Main finding
As reported in the abstract
- Remimazolam offers anesthesia without significant hemodynamic instability
- Reduced need for vasopressors
- Relevant for induction and maintenance of GA in catheterization laboratory procedures and GA in elective cardiac surgery
Safety
Perioperative adverse events
- Incidence comparable to that of other agents
Original publication
Remimazolam in Cardiac Anesthesia: Analysis of Recent Data. J Cardiothorac Vasc Anesth. Published 22 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →